2024 SPONSORS

At Extremity Care we offer a diverse portfolio of cell and tissue products - including placental allografts, xenografts, acellular dermis, and conservative wound care products.

We focus on technologies that support the repair, reconstruction, replacement, or supplementation of the patient’s own tissue. Through our dedicated lab and AATB accredited tissue bank we are at the forefront of cell and tissue engineering. We strive to be good stewards of the precious gift of tissue donation.

With our careLOG™ shipping logistics process, we provide just-in-time handling of cell and tissue products. careLOG™ contains the tissue, product information and the billing-related documents needed to request reimbursement.

.

From advanced wound care through surgery and sports medicine, we are committed to empowering healing by confidently and reliably delivering clinicians the range of regenerative tissue innovations along with the services they need. Designed for the management of chronic and acute wounds, our portfolio of advanced wound care solutions can support patients from early in the wound healing process through to wound closure—regardless of wound type.

Tides Medical is dedicated to revolutionizing access to the regenerative power of wound treatment technologies to eliminate pain and suffering caused by soft tissue conditions.

At 180 Health Services, we are committed to being your trusted partner in advanced medical solutions. Our mission is to deliver cutting edge, life-enhancing wound care products to providers throughout the country. We take pride in our extensive range of innovative skin graft biologics for the treatment of non-healing wounds.

ARANZ Medical’s innovative Silhouette charting solution is used by leading clinicians and has been customized to meet the needs of your wound care practice. Key features of Silhouette include high quality imaging, measurements including depth and volume, and comprehensive, configurable data gathering and reporting. Silhouette supports offline charting, making it perfect for mobile wound care practitioners to work without requiring an internet connection. Once connectivity is available, clinical data is synched directly with a central database. ​   With features designed to streamline workflows and enhance accuracy, come and talk to us about how Silhouette can transform your wound care practice.

GR Consulting, LLC is a small boutique consulting and advisory firm that specializes in the wound care and surgical wound care markets. GRc focuses on start-up and early-stage companies who need additional bandwidth to support their expanding business. We are a small team of senior leaders who provide support in strategy, geographic expansion, market access/reimbursement, health economics & outcomes research, regulatory, clinical trial design/execution, and strategic partner searches. Our team has more than 125 years of combined senior level experience and provides the leadership firepower, technical ingenuity, a strong industry network and the expertise to help execute the correct business strategy at the right time. Finally, our business model is set-up to deliver a customized approach to each client’s specific business needs without the bloated overhead and generalist approach that most mid-sized or large consulting firms provide.

Surgeons and scientists founded Imbed Biosciences to create breakthrough wound care technologies to positively impact the lives of patients with acute, chronic and traumatic wounds. Imbed is committed to bringing the most advanced wound care solutions to clinics and hospitals nationwide.

Kent Imaging, a leading innovator in tissue oxygenation assessment, designs and manufactures imaging technology that supports real-time decision-making in wound care, vascular and surgical specialties. Unlike some devices that only measure the macrovasculature, SnapshotNIR utilizes near-infrared light to go below the surface and measure tissue oxygen saturation, oxyhemoglobin, deoxyhemoglobin and total hemoglobin in the microvascular network. Use actionable data to document medical necessity, expedite vascular assessment, design treatment plans, and track and document therapeutic efficacy.

MIMEDX is a transformational placental biologics company, developing and distributing placental tissue allografts with patent-protected, proprietary processes for multiple sectors of healthcare. MIMEDX has supplied over two million allografts, through both direct and consignment shipments. For additional information, please visit www.mimedx.com.

The MIMOSA Pro consists of a pocket-sized imaging device and a HIPAA-compliant web portal that streamlines tissue health assessments by capturing temperature, tissue oxygenation, and digital images in less than one second. The images automatically upload to the web portal where clinicians can monitor patient progress and collaborate towards improved outcomes.

The MolecuLight i:X® and DX™ point-of-care imaging devices enable detection of elevated bacterial loads and accurate digital wound measurement. They facilitate proactive wound care & inform clinician decision-making in real-time including enabling guided cleaning & debridement. US reimbursement pathway is enabled, along with 80+ peer-reviewed publications.

NATROX® Wound Care leads the way in advanced therapies, sparked by one person's mission to improve the quality of life for a loved one suffering from a non-healing wound. Its flagship product, NATROX® O2, offers a discreet, wearable device that delivers the natural properties of topical oxygen, empowering patients in their wound-healing journey. Evolving from this vision, we offer innovative med-tech solutions to support clinicians worldwide in effectively managing a variety of chronic wounds.

New Day Medical Management provides business and clinical management services for Independent Wound Care Practices. Our custom designed operations and clinical systems help manage patient care, support accurate documentation, and assist with billing and revenue cycle management. We also directly assist with compliance and perform regular documentation reviews to protect both your clinicians and your practice.  With extensive experience in clinical administration, documentation compliance, and billing and reimbursement review, we have a full-service team dedicated to meeting whatever challenge your practice may be facing. Give your clinicians the tools and support they need to help manage even the most complex wound care cases, and set your wound care practice up for both clinical and financial success.

Reprise Biomedical is focused on the development and commercialization of biological medical devices that offer advanced solutions for wound healing. In 2019, Reprise took ownership of two products, under a proprietary perfusion decellularization technology license from the University of Minnesota, MiroDerm biologic wound matrix for advanced wound management and MiroFlex biologic matrix for soft tissue reinforcement. Reprise is committed to delivering novel solutions which address unmet surgical needs for advanced wound care. Our transformational, Miro3D wound matrix, is an example of that commitment.  Miro3D broadens our wound management portfolio by offering a unique three-dimensional solution for deep and tunneling wounds.   

Samaritan Biologics is a Tennessee based, minority owned small business located in Memphis with R&D and future manufacturing facilities based in Greenville South Carolina on the campus of Clemson University.  Samaritan was bootstrapped by 3 founders in 2019 and has no outside investment or physician ownership.  Our focus is the development and commercialization of human perinatal tissue allografts to enable doctors to more effectively treat patients for a wide variety of clinical goals including: Limb Preservation, Wound Care, Robotic Oncology, Neurosurgery, Urology, Sports Medicine and Orthopedics.  We pride ourselves on taking a scientific approach to perinatal tissues. We live our tagline everyday – Helping, Healing, Giving

Solventum, formerly 3M Health Care, focuses on providing better care through patient-centered science. From solutions designed to protect skin integrity to a full portfolio of advanced and surgical wound care, our team is ready to partner with you to help transform outcomes.

Stability Biologics is an innovative, regenerative medicine company, providing a full line of advanced biologic products to enhance the lives of patients and create greater surgeon satisfaction. ​

Stimlabs LLC’s mission is to advance the state of regenerative medicine, with a current focus in wound care and surgical applications. Comprised of industry leaders, StimLabs is dedicated to offering patients the best possible care while recognizing the urgency of providing solutions in areas with unmet needs. StimLabs has a comprehensive product portfolio addressing various clinical applications and has established a strong intellectual property catalog. Committed to delivering superior products, StimLabs is a trusted partner to physicians and patients alike.

Swift Medical is a digital wound care management solution with over 4,800 healthcare facilities utilizing its advanced AI-based platform to improve the prevention, treatment and management of wounds. More than 25 million wound images and 49 million assessments have been captured through Swift Skin & Wound, which has enabled healthcare providers to deliver standardized, accessible and equitable wound care with high-precision imaging, compliant documentation and clinical analytics.

The Journal of Wound Care (JWC) is the leading monthly peer-reviewed, international wound care journal. Publishing the latest, most relevant research and clinical expertise to support the delivery of best practice and innovation in wound care management and tissue viability. The official journal for the WUWHS, JWC is the only monthly journal to be Medline listed with an impact factor of 2.63.

SerenaGroup® is a global health care company with the mission of developing the world’s leading Comprehensive Wound Care and Research Centers. They are dedicated to advancing the science of wound healing by utilizing advanced modalities that lead to a positive patient experience and quality outcomes. The focus of SerenaGroup® is on the science as well as establishing a positive financial enterprise.